iShares U.S. Pharmaceuticals ETF (IHE)
| 191.41 Delayed Data As of 3:52pm ET |  +2.20 / +1.16%Today’s Change | 176.96 Today|||52-Week Range 202.77 | -4.12% Year-to-Date |
Investment Objective
The investment seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund is non-diversified.
Latest IHE News
| Is Invesco Dynamic Pharmaceuticals ETF (PJP) a Strong ETF Right Now? Aug 03 / Zacks.com - Paid Partner Content |
Performance
| 1 month | -2.96% | 3 years | +11.44% | |
| 3 months | +5.09% | 5 years | +6.40% | |
| 1 year | -0.20% | Since inception | +10.08% |
Data through 08/10/2022
Quote Details
| Previous close | $189.21 |
| Open day’s range | 190.34 – 191.51 |
| Net asset value (NAV) | 189.28 (08/09/2022) |
| Daily volume | 5,486 |
| Average volume (3 months) | 16,944 |
Data as of 3:52pm ET, 08/10/2022
Peer Comparisonvs. Health ETFs
| IHE | Category | |
|---|---|---|
| Performance 5-yr return | +6.40% | +7.33% |
| Expense Gross exp ratio | 0.39% | 1.01% |
| Risk 5 year sharpe ratio | 0.36 | 0.48 |
| Net assets | $447.5M | $2.0B |
| Average market cap | $67.9B | $43.6B |
| Average P/E | 18.4 | 22.0 |
| Dividend / Share | -- | 0.24% |
Competitors
| VHT Vanguard Health Care Index Fund ETF Shar... |
| FHLC Fidelity MSCI Health Care Index ETF |
| IEHS iShares Evolved U.S. Healthcare Staples ... |
Holdings
Top 5 SectorsPortfolio weighting
| Healthcare | 98.99% |
| Consumer goods | 1.01% |
| Business service | 0.00% |
| Consumer service | 0.00% |
| Energy | 0.00% |
Top 10 HoldingsPortfolio weighting
| JNJ Johnson & Johnson | 22.60% |
| PFE Pfizer | 19.75% |
| ZTS Zoetis Inc | 4.89% |
| LLY Eli Lilly and Co | 4.83% |
| RPRX Royalty Pharma PLC | 4.81% |
| CTLT Catalent Inc | 4.69% |
| MRK Merck | 4.59% |
| BMY Bristol-Myers Squibb | 4.45% |
| VTRS Viatris Inc | 3.75% |
| JAZZ Jazz Pharmaceuticals PLC | 3.65% |
